Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)

0 保存 · 1 分享 · 2 评论参与讨论

资助机构

National Institutes of Health (NIH)

Department of Health and Human Services (HHS)

地区

United States

研究领域

Health

截止日期

Sep 05, 2025 12:00:00 AM EDT

基金规模

$1,838,436

联系方式

National Institutes of Health OERWebmaster03@od.nih.gov

申请资格

Eligible Applicants:

Small businesses

Additional Information on Eligibility:

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

基金编号

PAS-22-196

说明

This Funding Opportunity Announcement (FOA) invites applications to the National Institute on Aging's (NIA) Small Business Innovation Research (SBIR) program. The aim of this FOA is to support research that may lead to the development of innovative products and/or services that have the potential to advance progress in preventing and treating Alzheimer's disease (AD) and AD-related dementias (ADRD) and/or caring for and treating patients living with AD/ADRD.

网站

http://grants.nih.gov/grants/guide/pa-files/PAS-22-196.html

基金资源
Purdue Grant Writing Lab: Introduction to Grant Writing	打开链接
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal	打开链接